Pharmacogenetics and therapeutic surveillance.
D000293:Adolescent; D000743:Anemia, Hemolytic / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control; D000929:Antidepressive Agents, Tricyclic / Q000097:blood / Q000378:metabolism / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D003863:Depression / Q000188:drug therapy; D064420:Drug-Related Side Effects and Adverse Reactions; D004534:Egypt; D005006:Ethnicity; D005955:Glucosephosphate Dehydrogenase Deficiency / Q000453:epidemiology; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007700:Kinetics; D008297:Male; D004364:Pharmaceutical Preparations / Q000378:metabolism; D010597:Pharmacogenetics; D011110:Polymorphism, Genetic; D014810:Vitamin E / Q000627:therapeutic use
D000929:Antidepressive Agents, Tricyclic; D004364:Pharmaceutical Preparations; D014810:Vitamin E